4.7 Article

Ubiquitin-dependent degradation of p73 is inhibited by PML

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 199, 期 11, 页码 1545-1557

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20031943

关键词

ubiquitinylation; acetylation; nuclear body; transcription; apoptosis

资金

  1. MRC [MC_U132670601] Funding Source: UKRI
  2. Medical Research Council [MC_U132670601] Funding Source: researchfish
  3. Medical Research Council [MC_U132670601] Funding Source: Medline
  4. NCI NIH HHS [R01-CA76584, CA-71692, R01 CA071692, R37 CA071692, R01 CA076584] Funding Source: Medline
  5. NIGMS NIH HHS [R01 GM057587, R01-GM57587] Funding Source: Medline

向作者/读者索取更多资源

p73 has been identified recently as a structural and functional homologue of the tumor suppressor p53. Here, we report that p73 stability is directly regulated by the ubiquitin-proteasome pathway. Furthermore, we show that the promyelocytic leukemia (PML) protein modulates p73 half-life by inhibiting its degradation in a PML-nuclear body (NB)-dependent manner. p38 mitogen-activated protein kinase-mediated phosphorylation of p73 is required for p73 recruitment into the PML-NB and subsequent PML-dependent p73 stabilization. We find that p300-mediated acetylation of p73 protects it against ubiquitinylation and that PML regulates p73 stability by positively modulating its acetylation levels. As a result, PML potentiates p73 transcriptional and proapoptotic activities that are markedly impaired in Pml(-/-) primary cells. Our findings demonstrate that PML plays a crucial role in modulating p73 function, thus providing further insights on the molecular network for tumor suppression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据